SAN DIEGO, Jan. 9, 2024 /PRNewswire/ -- Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced unaudited preliminary financial results for the fourth quarter and fiscal year 2023 ahead of its presentation at the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024 at 9:00am Pacific Time (12:00pm Eastern Time). The webcast can be accessed through the Investor Info section of Illumina's website at investor.illumina.com. Preliminary financial results Consolidated revenue of ap ...

Shares of gene sequencing leader Illumina (ILMN 2.44%) rallied 36.6% in December, according to data from S&P Global Market Intelligence.Investors might not be quite so excited, as Illumina entered the month more than 80% below its all-time highs from 2021. But hopes for a bottoming and recovery surfaced in December, as Illumina received several positive analyst notes, and activist investor Carl Icahn made his next move in shaking up the company's board of directors.Is the company at the start of its recover ...

Illumina, Inc. (ILMN) recently entered into an agreement with Janssen Research & Development, LLC (Janssen) to develop its novel molecular residual disease (MRD) assay. The assay is a multi-cancer whole-genome sequencing (WGS) research solution that detects circulating tumor DNA (ctDNA) to better understand disease persistence or recurrence following treatment intervention.It is worth mentioning that MRD testing is increasingly being used in cancer as a predictive indication of disease recurrence following ...

SAN DIEGO, Jan. 5, 2024 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced it has signed an agreement with Janssen Research & Development, LLC (Janssen). This collaboration will be the first relating to the development of Illumina's novel molecular residual disease (MRD) assay, a whole-genome sequencing (WGS) multi-cancer research solution that detects circulating tumor DNA (ctDNA) to better understand the persistence or recurrence o ...

SAN DIEGO, Jan. 4, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that it will issue results for the fourth quarter and full year 2023 following the close of market on Thursday, February 8, 2024.  On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Jacob Thaysen, Chief Executive Officer, and Joydeep Goswami, Chief Financial Officer and Chief Strategy and Corporate Development Officer, will host a conference call with analysts, investors, and other interested parties to discus ...

AGD delivered ~86,000 whole genomes in 2023, including a unique diverse ancestry cohortExpanded pharma engagement enhances AGD's ability to develop multiomic datasets SAN DIEGO, Jan. 4, 2024 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, in collaboration with Nashville Biosciences, LLC (NashBio), a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center (VUMC), today announced three new membe ...

NEW YORK--(BUSINESS WIRE)--Madryn Asset Management, LP (“Madryn Asset Management” and, collectively with its affiliates, “Madryn” or “we”), a holder of approximately 4.2% of the outstanding common stock of SomaLogic, Inc. (“SomaLogic” or the “Company”) (Nasdaq: SLGC), today reiterated its view that there is a viable alternative to the proposed merger (the “Proposed Merger”) with Standard BioTools Inc. (Nasdaq: LAB). Madryn issued the following statement: It is our view that SomaLogic’s considerable cash po ...

Illumina, Inc. (NASDAQ:ILMN) Piper Sandler 35th Annual Healthcare Conference November 29, 2023 11:30 AM ET Company Participants Jacob Thaysen - Chief Executive Officer Conference Call Participants David Westenberg - Piper Sandler David Westenberg All right. We're going to get started. Joining me is Illumina's brand-new CEO, and most important question here, can we call you Jacob or Jakob? Jacob Thaysen Well, normally, what I would say is that, my mother would call me Jakob, when we speak English -- Danish a ...

Illumina, Inc. (NASDAQ:ILMN) Evercore ISI 6th Annual HealthCONx Conference November 28, 2023 10:50 AM ET Company Participants Joydeep Goswami - Chief Financial Officer Salli Schwartz - Vice President, Investor Relations Conference Call Participants Vijay Kumar - Evercore ISI Vijay Kumar [Starts Abruptly] Everyone for joining us this morning. Pleasure to have with us Illumina. From the company, we have CFO Joydeep Goswami and from Investor Relations, we have Salli, and I'm Vijay Kumar, cover Life Science too ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended October 1, 2023 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 001-35406 Illumina, Inc. (Exact name of registrant as specified in its charter) Delaware 33-0804655 (State or other jurisdiction of incorporation ...